SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $297,000 | -64.6% | 249,473 | -3.2% | 0.00% | -66.7% |
| Q4 2021 | $840,000 | -27.4% | 257,690 | -0.5% | 0.00% | -40.0% |
| Q3 2021 | $1,157,000 | -21.8% | 258,938 | -4.6% | 0.01% | -28.6% |
| Q2 2021 | $1,480,000 | +118.9% | 271,508 | +200.4% | 0.01% | +133.3% |
| Q1 2021 | $676,000 | -46.0% | 90,381 | -21.6% | 0.00% | -40.0% |
| Q4 2020 | $1,251,000 | +33.1% | 115,326 | +8.5% | 0.01% | +25.0% |
| Q3 2020 | $940,000 | +6.1% | 106,321 | +27.9% | 0.00% | 0.0% |
| Q2 2020 | $886,000 | +218.7% | 83,112 | +77.4% | 0.00% | +100.0% |
| Q1 2020 | $278,000 | +261.0% | 46,842 | +318.2% | 0.00% | – |
| Q4 2019 | $77,000 | -79.4% | 11,201 | -72.3% | 0.00% | -100.0% |
| Q2 2019 | $374,000 | +1.4% | 40,370 | -0.0% | 0.00% | 0.0% |
| Q1 2019 | $369,000 | +77.4% | 40,380 | +8.3% | 0.00% | +100.0% |
| Q4 2018 | $208,000 | -53.6% | 37,280 | -0.9% | 0.00% | -50.0% |
| Q3 2018 | $448,000 | -26.7% | 37,630 | -37.2% | 0.00% | -33.3% |
| Q2 2018 | $611,000 | – | 59,890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|